| American Cancer Society Joins 'Million Moms Challenge' to Tackle 2nd Leading Cancer Killer in Women |
|
21/12/2011 01:45 (161 Day 16:55 minutes ago) | |||||
|
The FINANCIAL -- Although largely preventable through early detection, cervical cancer is the second leading cause of cancer death among women in developing countries, where more than 85 percent of the estimated 529,800 cervical cancer cases worldwide in 2008 occurred.
While cervical cancer screening rates have decreased by as much as 65 percent over the past four decades due to screening, incidence rates remain high in developing countries in Central and South America, the Caribbean, sub-Saharan Africa, and Southern Asia where girls and women do not have access to prevention services such as education, HPV vaccination and life-saving pre-cancer screening and early treatment.
As the world's leading voluntary health organization, the American Cancer Society lends its expertise and resources to the Million Moms Challenge to raise awareness about cervical cancer, a leading cause of death among women worldwide and a disease that affects maternal health, especially in developing countries.
The American Cancer Society recommends cervical cancer screening for women 18 and over approximately three years after a woman begins having vaginal intercourse, but no later than 21 years of age. Screening should be done every year with conventional Pap tests or every two years using liquid-based Pap tests. At or after age 30, women who have had three normal test results in a row may get screened every two to three years.
The American Cancer Society combines an unyielding passion with nearly a century of experience to save lives and end cancer for good. As a global grassroots force of three million volunteers, we fight for every birthday threatened by every cancer in every community.
We save lives by helping you stay well by preventing cancer or detecting it early, helping you get well by being there for you during and after a diagnosis, by finding cures through groundbreaking discovery and fighting back through public policy. As the nation's largest non-governmental investor in cancer research, contributing more than $3.5 billion, we turn what we know about cancer into what we do.
|
|
|


